Page last updated: 2024-09-03

parecoxib and Cancer of Cervix

parecoxib has been researched along with Cancer of Cervix in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Du, J; Lou, G; Luan, J; Ma, W; Wang, K	1

Trials

1 trial(s) available for parecoxib and Cancer of Cervix

Article	Year
Multi-dose parecoxib provides an immunoprotective effect by balancing T helper 1 (Th1), Th2, Th17 and regulatory T cytokines following laparoscopy in patients with cervical cancer. Molecular medicine reports, 2015, Volume: 11, Issue:4 Topics: Adult; Aged; Analgesics; Cytokines; Female; Hospitalization; Humans; Isoxazoles; Laparoscopy; Middle Aged; Neoplasm Staging; Pain Measurement; Pain, Postoperative; RNA, Messenger; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory; Th1 Cells; Th17 Cells; Th2 Cells; Uterine Cervical Neoplasms	2015

Article

Year

Multi-dose parecoxib provides an immunoprotective effect by balancing T helper 1 (Th1), Th2, Th17 and regulatory T cytokines following laparoscopy in patients with cervical cancer.

Molecular medicine reports, 2015, Volume: 11, Issue:4

Topics: Adult; Aged; Analgesics; Cytokines; Female; Hospitalization; Humans; Isoxazoles; Laparoscopy; Middle Aged; Neoplasm Staging; Pain Measurement; Pain, Postoperative; RNA, Messenger; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory; Th1 Cells; Th17 Cells; Th2 Cells; Uterine Cervical Neoplasms

2015